Completed
A Study to Assess the Pharmacokinetics and Safety of Single Doses of Anifrolumab in Healthy Subjects
NCT02601625
- Conditions
- Healthy Subjects, Pharmacokinetics, Safety
- Locations
-
- Research Site Baltimore, Maryland, United States